The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Organs-on-chips (OOC)-Global Market Insights and Sales Trends 2024
Synopsis
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
The global Organs-on-chips (OOC) market size is expected to reach US$ 195.5 million by 2029, growing at a CAGR of 18.0% from 2023 to 2029. The market is mainly driven by the significant applications of Organs-on-chips (OOC) in various end use industries. The expanding demands from the Drug Discovery, Toxicology Research and Other Applications,, are propelling Organs-on-chips (OOC) market. Heart, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver segment is estimated at % CAGR for the next seven-year period.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Organs-on-chips (OOC), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Organs-on-chips (OOC) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Organs-on-chips (OOC) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Organs-on-chips (OOC) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Organs-on-chips (OOC) covered in this report include AxoSim, BioIVT, Emulate, Elveflow, MIMETAS, Nortis, Hurel Corporation, InSphero and Tara Biosystems, etc.
The global Organs-on-chips (OOC) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AxoSim
BioIVT
Emulate
Elveflow
MIMETAS
Nortis
Hurel Corporation
InSphero
Tara Biosystems
TissUse
Global Organs-on-chips (OOC) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Organs-on-chips (OOC) market, Segment by Type:
Heart
Liver
Lung
Other Organs
Global Organs-on-chips (OOC) market, by Application
Drug Discovery
Toxicology Research
Other Applications
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Organs-on-chips (OOC) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
The global Organs-on-chips (OOC) market size is expected to reach US$ 195.5 million by 2029, growing at a CAGR of 18.0% from 2023 to 2029. The market is mainly driven by the significant applications of Organs-on-chips (OOC) in various end use industries. The expanding demands from the Drug Discovery, Toxicology Research and Other Applications,, are propelling Organs-on-chips (OOC) market. Heart, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver segment is estimated at % CAGR for the next seven-year period.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Organs-on-chips (OOC), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Organs-on-chips (OOC) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Organs-on-chips (OOC) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Organs-on-chips (OOC) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Organs-on-chips (OOC) covered in this report include AxoSim, BioIVT, Emulate, Elveflow, MIMETAS, Nortis, Hurel Corporation, InSphero and Tara Biosystems, etc.
The global Organs-on-chips (OOC) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AxoSim
BioIVT
Emulate
Elveflow
MIMETAS
Nortis
Hurel Corporation
InSphero
Tara Biosystems
TissUse
Global Organs-on-chips (OOC) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Organs-on-chips (OOC) market, Segment by Type:
Heart
Liver
Lung
Other Organs
Global Organs-on-chips (OOC) market, by Application
Drug Discovery
Toxicology Research
Other Applications
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Organs-on-chips (OOC) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Organs-on-chips (OOC)
1.1 Organs-on-chips (OOC) Market Overview
1.1.1 Organs-on-chips (OOC) Product Scope
1.1.2 Organs-on-chips (OOC) Market Status and Outlook
1.2 Global Organs-on-chips (OOC) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Organs-on-chips (OOC) Market Size by Region (2018-2029)
1.4 Global Organs-on-chips (OOC) Historic Market Size by Region (2018-2023)
1.5 Global Organs-on-chips (OOC) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Organs-on-chips (OOC) Market Size (2018-2029)
1.6.1 North America Organs-on-chips (OOC) Market Size (2018-2029)
1.6.2 Europe Organs-on-chips (OOC) Market Size (2018-2029)
1.6.3 Asia-Pacific Organs-on-chips (OOC) Market Size (2018-2029)
1.6.4 Latin America Organs-on-chips (OOC) Market Size (2018-2029)
1.6.5 Middle East & Africa Organs-on-chips (OOC) Market Size (2018-2029)
2 Organs-on-chips (OOC) Market by Type
2.1 Introduction
2.1.1 Heart
2.1.2 Liver
2.1.3 Lung
2.1.4 Other Organs
2.2 Global Organs-on-chips (OOC) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Organs-on-chips (OOC) Historic Market Size by Type (2018-2023)
2.2.2 Global Organs-on-chips (OOC) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Organs-on-chips (OOC) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Organs-on-chips (OOC) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Organs-on-chips (OOC) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Organs-on-chips (OOC) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Organs-on-chips (OOC) Revenue Breakdown by Type (2018-2029)
3 Organs-on-chips (OOC) Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery
3.1.2 Toxicology Research
3.1.3 Other Applications
3.2 Global Organs-on-chips (OOC) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Organs-on-chips (OOC) Historic Market Size by Application (2018-2023)
3.2.2 Global Organs-on-chips (OOC) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Organs-on-chips (OOC) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Organs-on-chips (OOC) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Organs-on-chips (OOC) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Organs-on-chips (OOC) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Organs-on-chips (OOC) Revenue Breakdown by Application (2018-2029)
4 Organs-on-chips (OOC) Competition Analysis by Players
4.1 Global Organs-on-chips (OOC) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organs-on-chips (OOC) as of 2022)
4.3 Date of Key Players Enter into Organs-on-chips (OOC) Market
4.4 Global Top Players Organs-on-chips (OOC) Headquarters and Area Served
4.5 Key Players Organs-on-chips (OOC) Product Solution and Service
4.6 Competitive Status
4.6.1 Organs-on-chips (OOC) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AxoSim
5.1.1 AxoSim Profile
5.1.2 AxoSim Main Business
5.1.3 AxoSim Organs-on-chips (OOC) Products, Services and Solutions
5.1.4 AxoSim Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.1.5 AxoSim Recent Developments
5.2 BioIVT
5.2.1 BioIVT Profile
5.2.2 BioIVT Main Business
5.2.3 BioIVT Organs-on-chips (OOC) Products, Services and Solutions
5.2.4 BioIVT Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.2.5 BioIVT Recent Developments
5.3 Emulate
5.3.1 Emulate Profile
5.3.2 Emulate Main Business
5.3.3 Emulate Organs-on-chips (OOC) Products, Services and Solutions
5.3.4 Emulate Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.3.5 Elveflow Recent Developments
5.4 Elveflow
5.4.1 Elveflow Profile
5.4.2 Elveflow Main Business
5.4.3 Elveflow Organs-on-chips (OOC) Products, Services and Solutions
5.4.4 Elveflow Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.4.5 Elveflow Recent Developments
5.5 MIMETAS
5.5.1 MIMETAS Profile
5.5.2 MIMETAS Main Business
5.5.3 MIMETAS Organs-on-chips (OOC) Products, Services and Solutions
5.5.4 MIMETAS Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.5.5 MIMETAS Recent Developments
5.6 Nortis
5.6.1 Nortis Profile
5.6.2 Nortis Main Business
5.6.3 Nortis Organs-on-chips (OOC) Products, Services and Solutions
5.6.4 Nortis Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.6.5 Nortis Recent Developments
5.7 Hurel Corporation
5.7.1 Hurel Corporation Profile
5.7.2 Hurel Corporation Main Business
5.7.3 Hurel Corporation Organs-on-chips (OOC) Products, Services and Solutions
5.7.4 Hurel Corporation Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.7.5 Hurel Corporation Recent Developments
5.8 InSphero
5.8.1 InSphero Profile
5.8.2 InSphero Main Business
5.8.3 InSphero Organs-on-chips (OOC) Products, Services and Solutions
5.8.4 InSphero Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.8.5 InSphero Recent Developments
5.9 Tara Biosystems
5.9.1 Tara Biosystems Profile
5.9.2 Tara Biosystems Main Business
5.9.3 Tara Biosystems Organs-on-chips (OOC) Products, Services and Solutions
5.9.4 Tara Biosystems Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.9.5 Tara Biosystems Recent Developments
5.10 TissUse
5.10.1 TissUse Profile
5.10.2 TissUse Main Business
5.10.3 TissUse Organs-on-chips (OOC) Products, Services and Solutions
5.10.4 TissUse Organs-on-chips (OOC) Revenue (US$ Million) & (2018-2023)
5.10.5 TissUse Recent Developments
6 North America
6.1 North America Organs-on-chips (OOC) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Organs-on-chips (OOC) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Organs-on-chips (OOC) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Organs-on-chips (OOC) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Organs-on-chips (OOC) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Organs-on-chips (OOC) Market Dynamics
11.1 Organs-on-chips (OOC) Industry Trends
11.2 Organs-on-chips (OOC) Market Drivers
11.3 Organs-on-chips (OOC) Market Challenges
11.4 Organs-on-chips (OOC) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
